Sort   by:  
 Page size 
TMEM106B is an endolysosomal transmembrane protein associated with many brain disorders, such as frontotemporal lobar degeneration, Alzheimer’s disease, and hypomyelinating leukodystrophy. In addition, recent cryo-EM studies have identified amyloid fibrils of carboxyl-terminal TMEM106B in the brains...
ORGANISM(S): Mus musculus (Mouse) 
2024-08-06 | PXD043192 | Pride
Background: The risk for dementia increases exponentially from the seventh decade of life. Identifying and understanding the biochemical changes that sensitize the ageing brain to neurodegeneration will provide new opportunities for dementia prevention and treatment. This study aimed to determine ho...
ORGANISM(S): Homo sapiens (Human) 
2023-09-21 | PXD043880 | Pride
Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits
Loss of Tmem106b leads to myelination deficits: implications for FTD treatment strategies
Genetic variants that define two distinct haplotypes at the TMEM106B locus have been implicated in multiple neurodegenerative diseases and in healthy brain aging. In frontotemporal dementia (FTD), the high expressing TMEM106B risk haplotype was shown to increase susceptibility for FTD with TDP-43 in...
ORGANISM(S): Mus musculus 
2020-02-15 | GSE145314 | GEO
TMEM106B coding variant is protective and deletion detrimental in a mouse model of tauopathy
The loss of Tmem106b results in an age-dependent loss of cerebellar Purkinje cells accompanied with motor function deficits. Tmem106b deficiency also results in lysosomal enlargement in both Purkinje cells and microglia, and increased neuroinflammation including complement system activation. These d...
ORGANISM(S): Mus musculus 
2021-01-20 | GSE165105 | GEO
Sort   by:  
 Page size